Repaglinide
NDC 60687-560, Repaglinide, tablet, from American Health Packaging.
- Product NDC
- 60687-560
- Status
- Listed
- Labeler
- American Health Packaging
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203820
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60687-560 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE1 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60687-560-21 | 60687056021 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dd1d8337-9903-4b8a-a9ea-569e4d134e74NADAC price for package 60687056021
GET /v1/drugs/nadac/60687056021
Use it
Look up 60687-560 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60687-560 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60687-560. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.